| 1 | 1 | | 1 of 1 |
|---|
| 2 | 2 | | HOUSE DOCKET, NO. 2220 FILED ON: 1/15/2025 |
|---|
| 3 | 3 | | HOUSE . . . . . . . . . . . . . . . No. 2502 |
|---|
| 4 | 4 | | The Commonwealth of Massachusetts |
|---|
| 5 | 5 | | _________________ |
|---|
| 6 | 6 | | PRESENTED BY: |
|---|
| 7 | 7 | | John Francis Moran and Samantha Montaño |
|---|
| 8 | 8 | | _________________ |
|---|
| 9 | 9 | | To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General |
|---|
| 10 | 10 | | Court assembled: |
|---|
| 11 | 11 | | The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: |
|---|
| 12 | 12 | | An Act to clarify prescription monitoring program activities. |
|---|
| 13 | 13 | | _______________ |
|---|
| 14 | 14 | | PETITION OF: |
|---|
| 15 | 15 | | NAME:DISTRICT/ADDRESS :DATE ADDED:John Francis Moran9th Suffolk1/15/2025Samantha Montaño15th Suffolk1/17/2025Carmine Lawrence Gentile13th Middlesex1/21/2025Mindy Domb3rd Hampshire2/5/2025 1 of 1 |
|---|
| 16 | 16 | | HOUSE DOCKET, NO. 2220 FILED ON: 1/15/2025 |
|---|
| 17 | 17 | | HOUSE . . . . . . . . . . . . . . . No. 2502 |
|---|
| 18 | 18 | | By Representatives Moran of Boston and Montaño of Boston, a petition (accompanied by bill, |
|---|
| 19 | 19 | | House, No. 2502) of John Francis Moran, Samantha Montaño and others for legislation to clarify |
|---|
| 20 | 20 | | prescription monitoring program activities. Public Health. |
|---|
| 21 | 21 | | The Commonwealth of Massachusetts |
|---|
| 22 | 22 | | _______________ |
|---|
| 23 | 23 | | In the One Hundred and Ninety-Fourth General Court |
|---|
| 24 | 24 | | (2025-2026) |
|---|
| 25 | 25 | | _______________ |
|---|
| 26 | 26 | | An Act to clarify prescription monitoring program activities. |
|---|
| 27 | 27 | | Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority |
|---|
| 28 | 28 | | of the same, as follows: |
|---|
| 29 | 29 | | 1 SECTION 1. Section 24A of chapter 94C of the General Laws, as appearing in the 2022 |
|---|
| 30 | 30 | | 2Official Edition, is hereby amended by inserting after subsection (m) the following subsection:- |
|---|
| 31 | 31 | | 3 (n) Notwithstanding subsection (a)(1), the department shall exclude testosterone from the |
|---|
| 32 | 32 | | 4list of drugs monitored in the prescription drug monitoring system. |
|---|
| 33 | 33 | | 5 SECTION 2. Immediately upon passage of this Act, the department shall delete from the |
|---|
| 34 | 34 | | 6prescription monitoring system established under said section 24A any existing data concerning |
|---|
| 35 | 35 | | 7the prescribing and dispensing of testosterone. |
|---|